HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) in Kazakhstan

Kazakhstan: HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) was 78.0% in 2014. ◆ Volatile

Latest (2014)
78.0%
Change on year
down 2.5%
World rank
58th
of 104 countries
All-time high
80.0%
in 2013
All-time low
11.0%
in 2009
Years of data
10
2005–2014

HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) in Kazakhstan, 2005–2014

204060802005200920142005: 412006: 382007: 122008: 152009: 112010: 262011: 202012: 232013: 802014: 78

Source: World Health Organization, Global Health Observatory.

Analysis

Kazakhstan recorded 78.0% for hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in 2014.

Compared with earlier readings it is down 2.5% on the previous year and up 90.2% over ten years.

Over the whole period, hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in Kazakhstan peaked at 80.0% in 2013 and was at its lowest, 11.0%, in 2009.

Kazakhstan ranks 58th of 104 countries on this measure, in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) in Kazakhstan, year by year

Annual values for HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%) in Kazakhstan, 2005 to 2014.
Year Value Change
2005 41.0%
2006 38.0% -7.3%
2007 12.0% -68.4%
2008 15.0% +25.0%
2009 11.0% -26.7%
2010 26.0% +136.4%
2011 20.0% -23.1%
2012 23.0% +15.0%
2013 80.0% +247.8%
2014 78.0% -2.5%

Averages by decade

DecadeAverage LowestHighest Years
2000s 23.4% 11.0% 41.0% 5
2010s 45.4% 20.0% 80.0% 5

Countries ranked near Kazakhstan

  1. 58 Nicaragua 78.0% compare
  2. 60 Viet Nam 76.0% compare
  3. 61 Mongolia 75.0% compare

See the full ranking of 117 places →

More health data for Kazakhstan

All data for Kazakhstan →

Frequently asked questions

What is hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in Kazakhstan?
Hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in Kazakhstan was 78.0% in 2014, according to World Health Organization, Global Health Observatory.
What is the highest hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) recorded in Kazakhstan?
The highest recorded value was 80.0% in 2013.
What is the lowest hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) recorded in Kazakhstan?
The lowest recorded value was 11.0% in 2009.
How does Kazakhstan rank for hiv-positive tb patients on cpt (co-trimoxazole preventive therapy)?
Kazakhstan ranks 58th out of 104 countries with data for 2014.
Is hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) rising or falling in Kazakhstan?
Over the last ten years it is up 90.2%. The long-run trend across the full record is volatile.
Where does this Kazakhstan data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) in Kazakhstan. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 11 September 2026, from https://health.statizoid.com/stat/hiv-positive-tb-patients-on-cpt-co-trimoxazole-preventive-therapy-percent/kazakhstan/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/hiv-positive-tb-patients-on-cpt-co-trimoxazole-preventive-therapy-percent/kazakhstan/">HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) in Kazakhstan</a> — Statizoid

About this data

Indicator
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
117 places, 985 data points, 2003–2014
Last refreshed